Commentary · 30 Dec 2024
CommentaryPublished 23 Sep 2022
Screening and Diagnostic tests for tuberculosis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Mycobacterium tuberculosis is the causative agent of tuberculosis. Whether the goal is to diagnose latent infection or active disease will influence how the tuberculosis test is conducted. It is crucial to pinpoint the illness site if active disease is detected. Prior to doing additional testing, sputum specimens should be examined for mycobacteria. Never declare an illness to be latent until ruling out active disease. Interferon gamma release assays might be helpful in some situations, although tuberculin skin testing is advised for identifying latent infection. In Australia, there are about 1000 new cases of tuberculosis detected each year. The majority of these patients were infected outside of Australia, and current transmission is uncommon and only occurs in tiny clusters.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 9 May 2019
Evaluation of the BD MGIT™ TBc identifi cation test for confi rmation of Mycobacterium tuberculosis complex (MTBC) from isolates cultured on solid media (7h11)
Research article · 13 Mar 2018
Diagnostic Accuracy of Xpert Mtb/Rif Assay in Stool Samples in Intrathoracic Childhood Tuberculosis
Conference abstract · 17 May 2017
Disease biomarkers for studies on tuberculosis (TB) and TB diagnostic applications
Conference abstract · 8 Dec 2016
VATS in diagnostic and management of pulmonary tuberculosis
More from this journal
The newest in Journal of Pulmonology and Clinical Research.
Short communication · 12 Aug 2025
Ards management: Advancements, personalization, outcomes.
Short communication · 12 Aug 2025
Lung cancer breakthroughs: Ai, biomarkers, targeted therapies.
Short communication · 12 Aug 2025
Biomarkers: Respiratory infections, ards, clinical advances.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pulmonology and Clinical Research
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Narasimhan Mathai”

